158 related articles for article (PubMed ID: 25399573)
21. Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications.
Li JL; Harris AL
Front Biosci (Landmark Ed); 2009 Jan; 14(8):3094-110. PubMed ID: 19273260
[TBL] [Abstract][Full Text] [Related]
22. Modulation of VEGF signalling output by the Notch pathway.
Siekmann AF; Covassin L; Lawson ND
Bioessays; 2008 Apr; 30(4):303-13. PubMed ID: 18348190
[TBL] [Abstract][Full Text] [Related]
23. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching.
Suchting S; Freitas C; le Noble F; Benedito R; Bréant C; Duarte A; Eichmann A
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3225-30. PubMed ID: 17296941
[TBL] [Abstract][Full Text] [Related]
24. Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanism.
Patenaude A; Fuller M; Chang L; Wong F; Paliouras G; Shaw R; Kyle AH; Umlandt P; Baker JH; Diaz E; Tong J; Minchinton AI; Karsan A
Cancer Res; 2014 May; 74(9):2402-11. PubMed ID: 24599126
[TBL] [Abstract][Full Text] [Related]
25. Developmental coronary maturation is disturbed by aberrant cardiac vascular endothelial growth factor expression and Notch signalling.
van den Akker NM; Caolo V; Wisse LJ; Peters PP; Poelmann RE; Carmeliet P; Molin DG; Gittenberger-de Groot AC
Cardiovasc Res; 2008 May; 78(2):366-75. PubMed ID: 18093989
[TBL] [Abstract][Full Text] [Related]
26. "Sprouting angiogenesis", a reappraisal.
Ribatti D; Crivellato E
Dev Biol; 2012 Dec; 372(2):157-65. PubMed ID: 23031691
[TBL] [Abstract][Full Text] [Related]
27. Intersegmental vessel formation in zebrafish: requirement for VEGF but not BMP signalling revealed by selective and non-selective BMP antagonists.
Cannon JE; Upton PD; Smith JC; Morrell NW
Br J Pharmacol; 2010 Sep; 161(1):140-9. PubMed ID: 20718746
[TBL] [Abstract][Full Text] [Related]
28. Notch controls retinal blood vessel maturation and quiescence.
Ehling M; Adams S; Benedito R; Adams RH
Development; 2013 Jul; 140(14):3051-61. PubMed ID: 23785053
[TBL] [Abstract][Full Text] [Related]
29. Involvement of FGF and BMP family proteins and VEGF in early human kidney development.
Carev D; Saraga M; Saraga-Babic M
Histol Histopathol; 2008 Jul; 23(7):853-62. PubMed ID: 18437684
[TBL] [Abstract][Full Text] [Related]
30. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
[TBL] [Abstract][Full Text] [Related]
31. Notch signalling and the regulation of angiogenesis.
Siekmann AF; Lawson ND
Cell Adh Migr; 2007; 1(2):104-6. PubMed ID: 19329884
[TBL] [Abstract][Full Text] [Related]
32. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
[TBL] [Abstract][Full Text] [Related]
33. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis.
Noguera-Troise I; Daly C; Papadopoulos NJ; Coetzee S; Boland P; Gale NW; Lin HC; Yancopoulos GD; Thurston G
Nature; 2006 Dec; 444(7122):1032-7. PubMed ID: 17183313
[TBL] [Abstract][Full Text] [Related]
34. Notch pathway targets proangiogenic regulator Sox17 to restrict angiogenesis.
Lee SH; Lee S; Yang H; Song S; Kim K; Saunders TL; Yoon JK; Koh GY; Kim I
Circ Res; 2014 Jul; 115(2):215-26. PubMed ID: 24755984
[TBL] [Abstract][Full Text] [Related]
35. Laminin-binding integrins induce Dll4 expression and Notch signaling in endothelial cells.
Estrach S; Cailleteau L; Franco CA; Gerhardt H; Stefani C; Lemichez E; Gagnoux-Palacios L; Meneguzzi G; Mettouchi A
Circ Res; 2011 Jul; 109(2):172-82. PubMed ID: 21474814
[TBL] [Abstract][Full Text] [Related]
36. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL
Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743
[TBL] [Abstract][Full Text] [Related]
37. Recombinant bone morphogenetic protein-2 induces up-regulation of vascular endothelial growth factor and interleukin 6 in human pre-osteoblasts: role of reactive oxygen species.
Akeel S; El-Awady A; Hussein K; El-Refaey M; Elsalanty M; Sharawy M; Al-Shabrawey M
Arch Oral Biol; 2012 May; 57(5):445-52. PubMed ID: 22041018
[TBL] [Abstract][Full Text] [Related]
38. Dynamics of endothelial cell behavior in sprouting angiogenesis.
Eilken HM; Adams RH
Curr Opin Cell Biol; 2010 Oct; 22(5):617-25. PubMed ID: 20817428
[TBL] [Abstract][Full Text] [Related]
39. Developmental and pathological angiogenesis.
Chung AS; Ferrara N
Annu Rev Cell Dev Biol; 2011; 27():563-84. PubMed ID: 21756109
[TBL] [Abstract][Full Text] [Related]
40. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions.
Hainaud P; Contrerès JO; Villemain A; Liu LX; Plouët J; Tobelem G; Dupuy E
Cancer Res; 2006 Sep; 66(17):8501-10. PubMed ID: 16951162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
